Your browser doesn't support javascript.
loading
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.
Liu, Xiaofan; Zhou, Hu; Hu, Yu; Yin, Jie; Li, Junmin; Chen, Wenming; Huang, Ruibin; Gong, Yuping; Luo, Chengwei; Mei, Heng; Ding, Bingjie; Gu, Chengyuan; Sun, Huiping; Leng, Yun; Ji, Dexiang; Li, Yan; Yin, Hongyan; Shi, Haiyan; Chen, Keyan; Wang, Jian; Fan, Songhua; Su, Weiguo; Yang, Renchi.
Afiliação
  • Liu X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy
  • Zhou H; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Hu Y; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yin J; The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Li J; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Chen W; Beijing Chaoyang Hospital of Capital Medical University, Beijing, China.
  • Huang R; The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Gong Y; West China Hospital of Sichuan University, Chengdu, China.
  • Luo C; Guangdong Provincial People's Hospital, Guangzhou, China.
  • Mei H; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ding B; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Gu C; The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Sun H; Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Leng Y; Beijing Chaoyang Hospital of Capital Medical University, Beijing, China.
  • Ji D; The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li Y; West China Hospital of Sichuan University, Chengdu, China.
  • Yin H; HUTCHMED, Shanghai, China.
  • Shi H; HUTCHMED, Shanghai, China.
  • Chen K; HUTCHMED, Shanghai, China.
  • Wang J; HUTCHMED, Shanghai, China.
  • Fan S; HUTCHMED, Shanghai, China.
  • Su W; HUTCHMED, Shanghai, China.
  • Yang R; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Key Laboratory of Gene Therapy
Lancet Haematol ; 10(6): e406-e418, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37028433
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Idioma: En Ano de publicação: 2023 Tipo de documento: Article